Who Owns FTXH?

First Trust Nasdaq Pharmaceuticals ETF — Institutional Ownership & 13F Holdings

$33.75

+0.44 (+1.33%)

Market Cap

$29.4M

Shares Outstanding

850,035

Institutional Holders

20

Total Inst. Value

$3.9M

% of Float Held

QoQ Holder Change

+4

Institutional data as of Q1 2025

New Positions

3

Closed Positions

4

Increased

8

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1GOLDMAN SACHS GROUP INC$535K19,472
2ENVESTNET ASSET MANAGEMENT INC$517K18,799
3Cambridge Investment Research Advisors, Inc.$455K16,567
4OLD MISSION CAPITAL LLCNew$433K15,740
5Ameritas Investment Partners, Inc.$421K15,320
6WMG Financial Advisors, LLC$354K12,895
7Vivaldi Capital Management LP$305K11,120
8CITADEL ADVISORS LLCNew$219K7,961
9MORGAN STANLEY$162K5,915
10BANK OF MONTREAL /CAN/$134K4,888

Biggest Buyers & Sellers This Quarter

Related Stocks

Frequently Asked Questions

How many institutional investors hold FTXH?

As of Q1 2025, 20 institutional investors report holding FTXH (First Trust Nasdaq Pharmaceuticals ETF) in their 13F filings.

Which hedge fund owns the most FTXH?

The largest institutional holder of FTXH is GOLDMAN SACHS GROUP INC with $535K in shares.

Are institutions buying or selling FTXH?

This quarter, 3 institutions opened new positions in FTXH and 4 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.